| 1 |
32192322 | Efficacy of hypofractionated radiotherapy combined with docetaxel in middle and advanced non-small cell lung cancer and its effects on serum MMP-9 and VEGF expressions. | 2021 Dec |
1 |
| 2 |
29288085 | Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. | 2018 Mar 1 |
5 |
| 3 |
30217885 | Retraction: Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer. | 2018 Sep 15 |
1 |
| 4 |
25514117 | Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel. | 2015 Nov |
2 |
| 5 |
24576804 | A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery. | 2014 May |
3 |
| 6 |
23867803 | Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma. | 2013 |
1 |
| 7 |
24489574 | Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma. | 2013 |
2 |
| 8 |
22308113 | Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate. | 2012 Jan |
1 |
| 9 |
21323568 | Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases. | 2011 Jul |
2 |
| 10 |
16651437 | Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. | 2006 May 1 |
3 |
| 11 |
12970892 | Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. | 2003 Sep |
1 |